Associate Professor Melinda Coughlan |
Researchers from Monash University’s Central Clinical School (CCS) have found that a drug that has already been tested on other inflammatory diseases can decrease kidney injury caused by diabetes.
Led by Associate Professor Melinda Coughlan from the Department of Diabetes, the five-year study is a collaboration between CCS, the School of Biomedical Sciences at the University of Queensland and the Department of Medicine, University of Melbourne.